Stimulation of granulocyte functions in vitro by imipenem and the renal enzyme inhibitor MK 0791.

著者: Gnarpe, H, Belsheim, J, Blomqvist, C, Lundbäck, A
出版事項 1984

Lead specificity of the maximum ST/heart rate slope response.

著者: Beattie, J M, Seibert, G B, Blomqvist, C G
出版事項 1985

Measurement of growth rate of lung metastases in 21 patients with bone or soft-tissue sarcoma.

著者: Blomqvist, C., Wiklund, T., Tarkkanen, M., Elomaa, I., Virolainen, M.
出版事項 1993

Haematological toxicity: a marker of adjuvant chemotherapy efficacy in stage II and III breast cancer.

著者: Saarto, T., Blomqvist, C., Rissanen, P., Auvinen, A., Elomaa, I.
出版事項 1997

Leucocyte nadir as a marker for chemotherapy efficacy in node-positive breast cancer treated with adjuvant CMF

著者: Poikonen, P, Saarto, T, Lundin, J, Joensuu, H, Blomqvist, C
出版事項 1999

Exercise testing in men with significant left main coronary disease.

著者: Nixon, J V, Lipscomb, K, Blomqvist, C G, Shapiro, W
出版事項 1979

Aminoterminal propeptide of type I procollagen (PINP) correlates to bone loss and predicts the efficacy of antiresorptive therapy in pre- and post-menopausal non-metastatic breast...

著者: Saarto, T., Blomqvist, C., Risteli, J., Risteli, L., Sarna, S., Elomaa, I.
出版事項 1998

Clodronate improves bone mineral density in post-menopausal breast cancer patients treated with adjuvant antioestrogens.

著者: Saarto, T., Blomqvist, C., Välimäki, M., Mäkelä, P., Sarna, S., Elomaa, I.
出版事項 1997

A probability model for predicting BRCA1 and BRCA2 mutations in breast and breast-ovarian cancer families

著者: Vahteristo, P, Eerola, H, Tamminen, A, Blomqvist, C, Nevanlinna, H
出版事項 2001

Tamoxifen treatment reverses the adverse effects of chemotherapy-induced ovarian failure on serum lipids

著者: Vehmanen, L, Saarto, T, Blomqvist, C, Taskinen, M-R, Elomaa, I
出版事項 2004

Radiation to supraclavicular and internal mammary lymph nodes in breast cancer increases the risk of stroke

著者: Nilsson, G, Holmberg, L, Garmo, H, Terent, A, Blomqvist, C
出版事項 2009

Type III collagen metabolism in soft tissue sarcomas.

著者: Wiklund, T. A., Elomaa, I., Blomqvist, C. P., Risteli, L., Risteli, J.
出版事項 1992

Type I and type III collagen metabolites in adult osteosarcoma patients.

著者: Wiklund, T., Blomqvist, C., Risteli, L., Risteli, J., Karaharju, E., Elomaa, I.
出版事項 1996

Markers of type I collagen degradation and synthesis in the monitoring of treatment response in bone metastases from breast carcinoma.

著者: Blomqvist, C., Risteli, L., Risteli, J., Virkkunen, P., Sarna, S., Elomaa, I.
出版事項 1996

Predictive value of c-erbB-2, p53, cathepsin-D and histology of the primary tumour in metastatic breast cancer.

著者: Niskanen, E., Blomqvist, C., Franssila, K., Hietanen, P., Wasenius, V. M.
出版事項 1997

The effect of clodronate and antioestrogens on bone loss associated with oestrogen withdrawal in postmenopausal women with breast cancer

著者: Saarto, T, Vehmanen, L, Elomaa, I, Välimäki, M, Mäkelä, P, Blomqvist, C
出版事項 2001

Incidence of arrhythmias induced by isometric and dynamic exercise.

著者: Atkins, J M, Matthews, O A, Blomqvist, C G, Mullins, C B
出版事項 1976

Do DNA ploidy and S-phase fraction in primary tumour predict the response to chemotherapy in metastatic breast cancer?

著者: Hietanen, P., Blomqvist, C., Wasenius, V. M., Niskanen, E., Franssila, K., Nordling, S.
出版事項 1995

Cathepsin-D, urokinase plasminogen activator and type-1 plasminogen activator inhibitor in early breast cancer: an immunohistochemical study of prognostic value and relations to te...

著者: Jahkola, T, Toivonen, T, Smitten, K von, Virtanen, I, Wasenius, V-M, Blomqvist, C
出版事項 1999

The combination of radiotherapy, adjuvant chemotherapy (cyclophosphamide-doxorubicin-ftorafur) and tamoxifen in stage II breast cancer. Long-term follow-up results of a randomised...

著者: Blomqvist, C., Tiusanen, K., Elomaa, I., Rissanen, P., Hietanen, T., Heinonen, E., Gröhn, P.
出版事項 1992